Influenza vaccination. need for immunization against influenza
Conditions
Interventions
Intervention 1: Intervention group: intradermal administration of seasonal influenza vaccine, 0.25ml, in forearm area in October 2009. Intervention 2: Control group: intramuscular administration of se
Prevention
Intervention group: intradermal administration of seasonal influenza vaccine, 0.25ml, in forearm area in October 2009
Control group: intramuscular administration of seasonal influenza vaccine, 0.5ml, in deltoid muscle in October 2009
Sponsors
Shiraz University of Medical Sciences & Health Services
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients under chronic hemodialysis Exclusion criteria: history of flu infection in a month, history of flu vaccination in 1388, hospitalization in last month, taking immune suppressants, hemodialysis less than two times a week
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti influenza antibody titer. Timepoint: Befor vaccination, one month after vaccination, three months after vaccination. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Influenza infection. Timepoint: Six months after vaccination. Method of measurement: History & Physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Saeian
Shiraz University of Medical Sciences & Health Services
Outcome results
None listed